Sonlicromanol in Post-COVID

NCT07298005 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Post COVID Condition

Interventions

DRUG: Sonlicromanol
DRUG: Placebo

Sponsor

Michele van Vugt

Collaborators

[object Object]
[object Object]